Carperitide in Acute Respiratory Distress Syndrome (ARDS)

NCT00030121 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL

Last updated 2008-02-20

No results posted yet for this study

Summary

The purpose of this study is to determine whether Carperitide is safe and effective in the management of Acute Respiratory Distress Syndrome (ARDS).

Conditions

  • Respiratory Distress Syndrome

Interventions

DRUG

recombinant human atrial natriuretic polypeptide

Sponsors & Collaborators

  • Suntory Pharmaceutical

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
1999-12-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00030121 on ClinicalTrials.gov